CINCINNATI (August 24, 2022) — Pig Works, the parent company of the Flying Pig Marathon, the Queen Bee Half, the TQL Beer Series and the FCC3, announced today that Cincinnati-based Medpace will be the title sponsor of the Queen Bee Half with a new four-year partnership running from 2022 to 2025. Medpace will also continue to sponsor the Flying Pig Marathon Bike Team.


“Medpace has been an important part of the Queen Bee and has previously sponsored our Queen Bee 4-Miler. We are excited to continue to grow our relationship and to have them step up and take on the title partnership for the half marathon starting in 2022,” said Iris Simpson Bush, Pig Works CEO. “Their partnership will further enhance the half marathon experience for the thousands of runners and walkers who participate. It’s particularly meaningful as the Queen Bee returns to its own traditional fall weekend.”


“Medpace is delighted to again be partnering with the Pig Works team to support the Flying Pig Marathon and Queen Bee,” said Stephen Ewald, Medpace, General Counsel.  “The Queen Bee title partnership aligns with our philanthropic approach to making a positive impact on our local community and also providing fun and meaningful health and wellness opportunities for our employees.” 


Ewald continued, “As an organization with a significant female employee base, Medpace supports the Queen Bee’s mission to promote the fun of fitness while raising funds for local charities, especially those focused on providing benefits to women.”


About Pig Works

Pig Works is the nonprofit 501(c)(3) parent organization behind the Flying Pig Marathon, the Queen Bee Half, the TQL Beer Series and the FCC3. Pig Works is a race experience company with three goals. First, to create fun participatory sporting events for individuals and groups of all ages, abilities, and backgrounds. Second, to contribute to charitable causes that support the growth and development of our community here in Cincinnati and beyond. And third, to promote a lifestyle that weaves movement and health into the fiber of our community and extends beyond the bounds of our event days. Learn more at 


About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,000 people across 41 countries. Visit